Prothena | Salgsomkostninger Og Administration



Selling And Administration Expenses Lave om Dato
Acadia Pharmaceuticals USD 126.37M 3.71M 2025-03
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
ALKERMES USD 171.7M 24.71M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Amgen USD 1.69B 191M 2025-03
Biogen USD 572.5M 104.8M 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Exelixis USD 134.33M 22.53M 2025-01
Incyte USD 325.69M 1.02M 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
MacroGenics USD 27.81M 13.71M 2024-12
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Prothena USD 16.85M 88K 2024-12
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12



Prothena Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.